Allergy Immunotherapy Market
Allergy Immunotherapy Market Size, Share & Trends Analysis Report by Type (Allergic Rhinitis, Allergic Asthma, Food Allergy, Drug Allergy, and Others), by Treatment (Subcutaneous Immunotherapy, Sublingual Immunotherapy), Forecast Period 2023-2030
Allergy immunotherapy market is anticipated to grow at a CAGR of 8.2% during the forecast period. Factor such as increasing awareness of allergies in patients is anticipated to propel the growth of the allergy immunotherapy industry. According to the World Allergy Organization, an increase in the pervasiveness of allergies has been witnessed and around 30% of the world population has allergic rhinitis. As per the Centers for Disease Control and Prevention (CDC), more than 8% of adults in the US suffer from sinusitis and hay fever. With the awareness created by these organizations; governments of different countries have sanctioned budgets for the R&D of allergy immunotherapy as an effective cure. Thus, this factor has a positive impact on the growth of the allergy immunotherapy market during the forecast period.
The factors such as the growing prevalence of gastrointestinal diseases, rising investments, and funding in the field of life science research boost the growth of the allergy immunotherapy market during the forecast period. Allergy immunotherapy is also known as hypo-sensitization. It is a type of medical treatment that allows for tackling various types of allergies. There has been significant growth in the various types of allergies across the globe. Pharmacotherapy is not enough to tackle and control the occurrence of these allergic disorders. Therefore, it is a major driving factor for the development of the allergy immunotherapy market. The use of these treatments enables building up the tolerance level against the allergic substances and enables altering the course of the disorders.
Segmental Outlook
The global allergy immunotherapy market is segmented based on treatment, type, and distribution channel. Based on type, the market is segmented into allergic rhinitis, allergic asthma, food allergy, drug allergy, and others. The asthma segment is expected to hold a significant market share due to the growing prevalence of asthma across the globe. Based on treatment, the market is bifurcated into subcutaneous immunotherapy and sublingual immunotherapy. The subcutaneous immunotherapy segment is expected to hold a considerable growth rate during the forecast period due to its effectiveness in treating several allergies such as asthma. Moreover, it is treatment options that have to alter one's immune system to cure the development of other allergies.
Allergic Rhinitis will be the largest segment
Based on type, the market is segmented into allergic rhinitis, allergic asthma, food allergy, drug allergy, and others. The allergic rhinitis segment is expected to hold the largest market share in the allergy immunotherapy market. As per the Center for CDC around 8% of the total population is suffering from allergic rhinitis in the US. Therefore, the rising prevalence among adults and children is expected to propel the growth of the segment.
Regional Outlooks
The global Allergy Immunotherapy market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe market is anticipated to cater to a prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the Allergy Immunotherapy market.
Global Allergy Immunotherapy Market Growth, by Region 2023-2030
The North American Region is anticipated to Hold a Significant Share in the Global Allergy Immunotherapy Market
Among these regions, the Asia-Pacific region is anticipated to account for a significant share of the Allergy Immunotherapy market during the forecast period. The growth of the allergy immunotherapy market in the region is primarily driven by factors such as the growing number of patients suffering from various types of allergies, and the growing prevalence of chronic diseases such as hypertension, asthma, allergies, and diabetes that fuel the growth of the allergy immunotherapy market. Along with it, the growing prevalence of allergic asthma, eczema, and food allergy improved healthcare facilities, growing funds from R&D, and the development of new products and therapy is also contributed to the market share in the region.
Market Players Outlook
The key players of the allergy immunotherapy market include Biomay AG, Aimmune Therapeutics, Inc., HAL Allergy Group, Allergopharma, Merck KGaA, Stallergenes Greer, Jubilant Life Sciences, Ltd., ALK-Abello A/S, Leti Pharma, and DBV Technologies. These market players are continuously adopting various strategies to expand their market share. For instance, in November 2018, Aimmune Therapeutics, Inc announced the closing of the $98 million equity investment by Nestlé Health Science. The funding was provided to develop treatments for potentially life-threatening food allergies. Further, in October 2017, DBV Technologies entered into an R&D agreement for the treatment of birch allergies with standergness SA.
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global allergy immunotherapy market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Market Players
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Key Strategy Analysis
4. Market Segmentation
4.1. Global Allergy Immunotherapy Market by Type
4.1.1. Allergic Rhinitis
4.1.2. Allergic Asthma
4.1.3. Food Allergy
4.1.4. Drug Allergy
4.1.5. Others
4.2. Global Allergy Immunotherapy Market by Treatment
4.2.1. Subcutaneous Immunotherapy
4.2.2. Sublingual Immunotherapy
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Aimmune Therapeutics, Inc.
6.2. ALK-Abello A/S
6.3. Allergopharma (A Division of Merck KGaA)
6.4. Allergy Therapeutics PLC
6.5. Biomay AG
6.6. CircassiaPharmaceuticals PLC
6.7. DBV Technologies S.A.
6.8. Desentum Oy
6.9. HAL Allergy Group
6.10. Jubilant Life Sciences, Ltd.
6.11. LetiPharma
6.12. Merck KGaA
6.13. Sandoz, Inc.
6.14. Stallergenes GREER, Ltd.
6.15. Torii Pharmaceutical Co, Ltd.
1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
2. GLOBAL IMMUNOTHERAPY FOR ALLERGIC RHINITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
3. GLOBAL IMMUNOTHERAPY FOR ALLERGIC ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
4. GLOBAL IMMUNOTHERAPY FOR FOOD ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
5. GLOBAL IMMUNOTHERAPY FOR DRUG ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
6. GLOBAL IMMUNOTHERAPY FOR OTHERS ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
8. GLOBAL SUBCUTANEOUS ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
9. GLOBAL SUBLINGUAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
10. GLOBAL ALLERGY IMMUNOTHERAPY FOR HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
11. GLOBAL ALLERGY IMMUNOTHERAPY FOR RETAIL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
12. GLOBAL ALLERGY IMMUNOTHERAPY FOR ONLINE PHARMACY ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
13. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
14. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
15. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
16. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
17. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
18. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
19. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
20. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
21. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
22. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
23. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY TYPE, 2022 VS 2030 (%)
2. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY TREATMENT, 2022 VS 2030 (%)
3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
4. GLOBAL IMMUNOTHERAPY FOR ALLERGIC RHINITIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
5. GLOBAL IMMUNOTHERAPY FOR ALLERGIC ASTHMA MARKET SHARE BY REGION, 2022 VS 2030 (%)
6. GLOBAL IMMUNOTHERAPY FOR FOOD ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
7. GLOBAL IMMUNOTHERAPY FOR DRUG ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
8. GLOBAL IMMUNOTHERAPY FOR OTHERS ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
9. GLOBAL SUBCUTANEOUS ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
10. GLOBAL SUBLINGUAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
11. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
12. GLOBAL ALLERGY IMMUNOTHERAPY FOR HOSPITAL PHARMACY MARKET SHARE BY REGION, 2022 VS 2030 (%)
13. GLOBAL ALLERGY IMMUNOTHERAPY FOR RETAIL PHARMACY MARKET SHARE BY REGION, 2022 VS 2030 (%)
14. GLOBAL ALLERGY IMMUNOTHERAPY FOR ONLINE PHARMACY ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
15. US ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
16. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
17. UK ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
18. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
19. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
20. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
21. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
22. ROE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
23. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
24. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
25. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
26. REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
27. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
